Audience Choice Award for Jan Feifel at the 10th Anniversary Scientific Symposium of the European Innovative Medicines Initiative

Ulm University

The Innovative Medicines Initiative (IMI) is a partnership between the European Union and the European pharmaceutical industry. The Institute of Statistics participates in the IMI COMBACTE projects to fight antibiotic resistant bacteria. Jan Feifel's contribution to IMI's 10th Anniversary Scientific Symposium on cost-effective study designs for rare time-dependent exposures received the Audience Choice Award. See for further details